{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T14:12:59Z","timestamp":1792591979857,"version":"4.5.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,7,27]],"date-time":"2024-07-27T00:00:00Z","timestamp":1722038400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,7,27]],"date-time":"2024-07-27T00:00:00Z","timestamp":1722038400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biochem Genet"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1007\/s10528-024-10893-4","type":"journal-article","created":{"date-parts":[[2024,7,27]],"date-time":"2024-07-27T00:01:52Z","timestamp":1722038512000},"page":"3640-3655","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["ADAM12 Silencing Mediated by FOXC2 Represses Meningioma Progression Through Inactivating the JAK1\/STAT3\/VEGFA Pathway"],"prefix":"10.1007","volume":"63","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-1203-8444","authenticated-orcid":false,"given":"Huaming","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-3305-8635","authenticated-orcid":false,"given":"Bing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,27]]},"reference":[{"issue":"3","key":"10893_CR1","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1080\/14737175.2018.1429920","volume":"18","author":"C Apra","year":"2018","unstructured":"Apra C, Peyre M, Kalamarides M (2018) Current treatment options for meningioma. Expert Rev Neurother 18(3):241\u2013249","journal-title":"Expert Rev Neurother"},{"issue":"2","key":"10893_CR2","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s10735-020-09940-2","volume":"52","author":"S Bernatz","year":"2021","unstructured":"Bernatz S et al (2021) Influence of VEGF-A, VEGFR-1-3, and neuropilin 1\u20132 on progression-free: and overall survival in WHO grade II and III meningioma patients. J Mol Histol 52(2):233\u2013243","journal-title":"J Mol Histol"},{"key":"10893_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchemneu.2020.101846","volume":"109","author":"HG Bernstein","year":"2020","unstructured":"Bernstein HG et al (2020) From putative brain tumor marker to high cognitive abilities: emerging roles of a disintegrin and metalloprotease (ADAM) 12 in the brain. J Chem Neuroanat 109:101846","journal-title":"J Chem Neuroanat"},{"issue":"11","key":"10893_CR4","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1038\/s41568-019-0196-7","volume":"19","author":"JH Bushweller","year":"2019","unstructured":"Bushweller JH (2019) Targeting transcription factors in cancer\u2014from undruggable to reality. Nat Rev Cancer 19(11):611\u2013624","journal-title":"Nat Rev Cancer"},{"issue":"D1","key":"10893_CR5","doi-asserted-by":"publisher","first-page":"D165","DOI":"10.1093\/nar\/gkab1113","volume":"50","author":"JA Castro-Mondragon","year":"2022","unstructured":"Castro-Mondragon JA et al (2022) JASPAR 2022: the 9th release of the open-access database of transcription factor binding profiles. Nucleic Acids Res 50(D1):D165\u2013D173","journal-title":"Nucleic Acids Res"},{"issue":"8","key":"10893_CR6","first-page":"8632","volume":"13","author":"N Chen","year":"2021","unstructured":"Chen N et al (2021) The regulatory relationship and function of LncRNA FAM225A-miR-206-ADAM12 in gastric cancer. Am J Transl Res 13(8):8632\u20138652","journal-title":"Am J Transl Res"},{"issue":"12","key":"10893_CR7","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1007\/s11910-020-01084-w","volume":"20","author":"PD Delgado-Lopez","year":"2020","unstructured":"Delgado-Lopez PD et al (2020) A practical overview on the molecular biology of meningioma. Curr Neurol Neurosci Rep 20(12):62","journal-title":"Curr Neurol Neurosci Rep"},{"key":"10893_CR8","doi-asserted-by":"publisher","first-page":"153303382110384","DOI":"10.1177\/15330338211038492","volume":"20","author":"L Deng","year":"2021","unstructured":"Deng L et al (2021) NANOG promotes cell proliferation, invasion, and stemness via IL-6\/STAT3 signaling in Esophageal squamous carcinoma. Technol Cancer Res Treat 20:15330338211038492","journal-title":"Technol Cancer Res Treat"},{"issue":"10","key":"10893_CR9","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1093\/neuonc\/noy057","volume":"20","author":"Z Du","year":"2018","unstructured":"Du Z et al (2018) Meningioma transcription factors link cell lineage with systemic metabolic cues. Neuro Oncol 20(10):1331\u20131343","journal-title":"Neuro Oncol"},{"issue":"1","key":"10893_CR10","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s12943-017-0599-6","volume":"16","author":"S Duhachek-Muggy","year":"2017","unstructured":"Duhachek-Muggy S et al (2017) Metalloprotease-disintegrin ADAM12 actively promotes the stem cell-like phenotype in claudin-low breast cancer. Mol Cancer 16(1):32","journal-title":"Mol Cancer"},{"issue":"12","key":"10893_CR11","doi-asserted-by":"publisher","first-page":"2036","DOI":"10.1242\/jcs.198200","volume":"130","author":"MA Eckert","year":"2017","unstructured":"Eckert MA et al (2017) ADAM12 induction by Twist1 promotes tumor invasion and metastasis via regulation of invadopodia and focal adhesions. J Cell Sci 130(12):2036\u20132048","journal-title":"J Cell Sci"},{"issue":"4","key":"10893_CR12","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1007\/s00428-014-1641-3","volume":"465","author":"EA El-Habr","year":"2014","unstructured":"El-Habr EA et al (2014) Complex interactions between the components of the PI3K\/AKT\/mTOR pathway, and with components of MAPK, JAK\/STAT and Notch-1 pathways, indicate their involvement in meningioma development. Virchows Arch 465(4):473\u2013485","journal-title":"Virchows Arch"},{"issue":"7","key":"10893_CR13","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.1111\/jcmm.17228","volume":"26","author":"F Erdogan","year":"2022","unstructured":"Erdogan F et al (2022) JAK-STAT core cancer pathway: An integrative cancer interactome analysis. J Cell Mol Med 26(7):2049\u20132062","journal-title":"J Cell Mol Med"},{"key":"10893_CR14","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/B978-0-12-822198-3.00044-6","volume":"170","author":"DM Fountain","year":"2020","unstructured":"Fountain DM, Young AMH, Santarius T (2020) Malignant meningiomas. Handb Clin Neurol 170:245\u2013250","journal-title":"Handb Clin Neurol"},{"issue":"1","key":"10893_CR15","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.bbrc.2018.02.078","volume":"497","author":"X Guan","year":"2018","unstructured":"Guan X et al (2018) PUM1 promotes ovarian cancer proliferation, migration and invasion. Biochem Biophys Res Commun 497(1):313\u2013318","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"10893_CR16","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/s41392-021-00791-1","volume":"6","author":"X Hu","year":"2021","unstructured":"Hu X et al (2021) The JAK\/STAT signaling pathway: from bench to clinic. Signal Transduct Target Ther 6(1):402","journal-title":"Signal Transduct Target Ther"},{"key":"10893_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.729230","volume":"11","author":"Z Huang","year":"2021","unstructured":"Huang Z et al (2021) Upregulation of ADAM12 is associated with a poor survival and immune cell infiltration in colon adenocarcinoma. Front Oncol 11:729230","journal-title":"Front Oncol"},{"key":"10893_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.579599","volume":"10","author":"K Huntoon","year":"2020","unstructured":"Huntoon K, Toland AMS, Dahiya S (2020) Meningioma: a review of clinicopathological and molecular aspects. Front Oncol 10:579599","journal-title":"Front Oncol"},{"issue":"1","key":"10893_CR19","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1002\/hed.26918","volume":"44","author":"Z Jing","year":"2022","unstructured":"Jing Z et al (2022) FOXC2\/ADAM12-dependent radiosensitivity of head and neck squamous cell carcinoma cells. Head Neck 44(1):212\u2013225","journal-title":"Head Neck"},{"issue":"1","key":"10893_CR20","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s11060-011-0736-9","volume":"107","author":"MD Johnson","year":"2012","unstructured":"Johnson MD et al (2012) Cerebrospinal fluid stimulates leptomeningeal and meningioma cell proliferation and activation of STAT3. J Neurooncol 107(1):121\u2013131","journal-title":"J Neurooncol"},{"issue":"4","key":"10893_CR21","doi-asserted-by":"publisher","first-page":"2432","DOI":"10.3892\/ol.2017.5736","volume":"13","author":"M Johnson","year":"2017","unstructured":"Johnson M, O\u2019Connell M, Walter K (2017) STAT3 activation and risk of recurrence in meningiomas. Oncol Lett 13(4):2432\u20132436","journal-title":"Oncol Lett"},{"key":"10893_CR22","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1186\/1471-2105-9-559","volume":"9","author":"P Langfelder","year":"2008","unstructured":"Langfelder P, Horvath S (2008) WGCNA: an R package for weighted correlation network analysis. BMC Bioinform 9:559","journal-title":"BMC Bioinform"},{"issue":"2","key":"10893_CR23","doi-asserted-by":"publisher","first-page":"111","DOI":"10.3727\/096504013X13814233062171","volume":"21","author":"W Li","year":"2013","unstructured":"Li W et al (2013) FOXC2 often overexpressed in glioblastoma enhances proliferation and invasion in glioblastoma cells. Oncol Res 21(2):111\u2013120","journal-title":"Oncol Res"},{"issue":"6","key":"10893_CR24","doi-asserted-by":"publisher","first-page":"3231","DOI":"10.3892\/or.2015.4317","volume":"34","author":"Z Li","year":"2015","unstructured":"Li Z et al (2015) Expression of ADAM12 is regulated by E2F1 in small cell lung cancer. Oncol Rep 34(6):3231\u20133237","journal-title":"Oncol Rep"},{"issue":"3","key":"10893_CR25","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1159\/000447818","volume":"39","author":"C Li","year":"2016","unstructured":"Li C et al (2016) Forkhead box protein C2 promotes epithelial-mesenchymal transition, migration and invasion in cisplatin-resistant human ovarian cancer cell line (SKOV3\/CDDP). Cell Physiol Biochem 39(3):1098\u20131110","journal-title":"Cell Physiol Biochem"},{"issue":"2","key":"10893_CR26","doi-asserted-by":"publisher","first-page":"CNS72","DOI":"10.2217\/cns-2021-0003","volume":"10","author":"I Maggio","year":"2021","unstructured":"Maggio I et al (2021) Meningioma: not always a benign tumor A review of advances in the treatment of meningiomas. CNS Oncol 10(2):CNS72","journal-title":"CNS Oncol"},{"key":"10893_CR27","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.727306","volume":"11","author":"G Mu","year":"2021","unstructured":"Mu G et al (2021) Calmodulin 2 facilitates angiogenesis and metastasis of gastric cancer via STAT3\/HIF-1A\/VEGF-A mediated macrophage polarization. Front Oncol 11:727306","journal-title":"Front Oncol"},{"key":"10893_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.112537","volume":"146","author":"S Nomiri","year":"2022","unstructured":"Nomiri S et al (2022) Exploiting systems biology to investigate the gene modules and drugs in ovarian cancer: a hypothesis based on the weighted gene co-expression network analysis. Biomed Pharmacother 146:112537","journal-title":"Biomed Pharmacother"},{"issue":"6","key":"10893_CR29","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/s41419-020-2633-7","volume":"11","author":"K Pan","year":"2020","unstructured":"Pan K, Xie Y (2020) LncRNA FOXC2-AS1 enhances FOXC2 mRNA stability to promote colorectal cancer progression via activation of Ca(2+)-FAK signal pathway. Cell Death Dis 11(6):434","journal-title":"Cell Death Dis"},{"issue":"6","key":"10893_CR30","doi-asserted-by":"publisher","first-page":"2309","DOI":"10.3892\/ijo.2016.3739","volume":"49","author":"HK Rooprai","year":"2016","unstructured":"Rooprai HK et al (2016) Comparative gene expression profiling of ADAMs, MMPs, TIMPs, EMMPRIN, EGF-R and VEGFA in low grade meningioma. Int J Oncol 49(6):2309\u20132318","journal-title":"Int J Oncol"},{"issue":"11","key":"10893_CR31","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1158\/1541-7786.MCR-17-0188","volume":"15","author":"R Roy","year":"2017","unstructured":"Roy R et al (2017) ADAM12 Is a novel regulator of tumor angiogenesis via STAT3 signaling. Mol Cancer Res 15(11):1608\u20131622","journal-title":"Mol Cancer Res"},{"issue":"1","key":"10893_CR32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0085936","volume":"9","author":"S Shao","year":"2014","unstructured":"Shao S et al (2014) ADAM-12 as a diagnostic marker for the proliferation, migration and invasion in patients with small cell lung cancer. PLoS ONE 9(1):e85936","journal-title":"PLoS ONE"},{"key":"10893_CR33","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1016\/j.biopha.2017.11.034","volume":"97","author":"J Wang","year":"2018","unstructured":"Wang J et al (2018) ADAM12 induces EMT and promotes cell migration, invasion and proliferation in pituitary adenomas via EGFR\/ERK signaling pathway. Biomed Pharmacother 97:1066\u20131077","journal-title":"Biomed Pharmacother"},{"issue":"5","key":"10893_CR34","first-page":"1162","volume":"56","author":"L Wang","year":"2020","unstructured":"Wang L et al (2020a) ADAM12 silencing promotes cellular apoptosis by activating autophagy in choriocarcinoma cells. Int J Oncol 56(5):1162\u20131174","journal-title":"Int J Oncol"},{"key":"10893_CR35","doi-asserted-by":"publisher","first-page":"6353814","DOI":"10.1155\/2020\/6353814","volume":"2020","author":"J Wang","year":"2020","unstructured":"Wang J et al (2020c) Identification of a transcription factor-microRNA-gene coregulation network in meningioma through a bioinformatic analysis. Biomed Res Int 2020:6353814","journal-title":"Biomed Res Int"},{"key":"10893_CR36","doi-asserted-by":"publisher","first-page":"4305","DOI":"10.2147\/OTT.S242854","volume":"13","author":"H Wang","year":"2020","unstructured":"Wang H, Wu J, Guo W (2020b) SP1-Mediated upregulation of lncRNA LINC01614 functions a ceRNA for miR-383 to facilitate glioma progression through regulation of ADAM12. Onco Targets Ther 13:4305\u20134318","journal-title":"Onco Targets Ther"},{"key":"10893_CR37","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/617316","volume":"2015","author":"X Wu","year":"2015","unstructured":"Wu X et al (2015) Silencing of Eag1 gene inhibits osteosarcoma proliferation and migration by targeting STAT3-VEGF pathway. Biomed Res Int 2015:617316","journal-title":"Biomed Res Int"},{"issue":"6","key":"10893_CR38","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1007\/s13577-021-00583-3","volume":"34","author":"J Yan","year":"2021","unstructured":"Yan J et al (2021) FOXC2-AS1 stabilizes FOXC2 mRNA via association with NSUN2 in gastric cancer cells. Hum Cell 34(6):1755\u20131764","journal-title":"Hum Cell"},{"issue":"7","key":"10893_CR39","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1007\/s00432-009-0743-9","volume":"136","author":"MX Zhang","year":"2010","unstructured":"Zhang MX et al (2010) Constitutive activation of signal transducer and activator of transcription 3 regulates expression of vascular endothelial growth factor in human meningioma differentiation. J Cancer Res Clin Oncol 136(7):981\u2013988","journal-title":"J Cancer Res Clin Oncol"},{"issue":"4","key":"10893_CR40","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.7314\/APJCP.2014.15.4.1589","volume":"15","author":"CH Zheng","year":"2014","unstructured":"Zheng CH et al (2014) Expression of transcription factor FOXC2 in cervical cancer and effects of silencing on cervical cancer cell proliferation. Asian Pac J Cancer Prev 15(4):1589\u20131595","journal-title":"Asian Pac J Cancer Prev"},{"key":"10893_CR41","doi-asserted-by":"crossref","unstructured":"Hargadon KM, Goodloe TB 3rd, Lloyd ND (2022) Oncogenic functions of the FOXC2 transcription factor: a hallmarks of cancer perspective. Cancer Metastasis Rev","DOI":"10.1007\/s10555-022-10045-3"},{"key":"10893_CR42","doi-asserted-by":"crossref","unstructured":"\u0141ukaszewicz-Zaj\u0105c M, Dulewicz M, Mroczko B (2021) A disintegrin and metalloproteinase (ADAM) family: their significance in malignant tumors of the central nervous system (CNS). Int J Mol Sci 22(19)","DOI":"10.3390\/ijms221910378"},{"key":"10893_CR43","doi-asserted-by":"crossref","unstructured":"Ogasawara C, Philbrick BD, Adamson DC (2021) Meningioma: a review of epidemiology, pathology, diagnosis, treatment, and future directions. Biomedicines 9(3)","DOI":"10.3390\/biomedicines9030319"},{"key":"10893_CR44","doi-asserted-by":"crossref","unstructured":"Pawloski JA et al (2021) Genomic biomarkers of meningioma: a focused review. Int J Mol Sci 22(19)","DOI":"10.3390\/ijms221910222"},{"key":"10893_CR45","doi-asserted-by":"crossref","unstructured":"Schumacher N, Rose-John S (2019) ADAM17 activity and IL-6 trans-signaling in inflammation and cancer. Cancers (Basel) 11(11)","DOI":"10.3390\/cancers11111736"},{"key":"10893_CR46","doi-asserted-by":"crossref","unstructured":"Wang R et al (2021a) Hypoxia-inducible factor-dependent ADAM12 expression mediates breast cancer invasion and metastasis. Proc Natl Acad Sci USA 118(19)","DOI":"10.1073\/pnas.2020490118"},{"key":"10893_CR47","doi-asserted-by":"crossref","unstructured":"Wang YS et al (2021b) (20S) Ginsenoside Rh2 inhibits STAT3\/VEGF signaling by targeting annexin A2. Int J Mol Sci 22(17)","DOI":"10.3390\/ijms22179289"},{"key":"10893_CR48","doi-asserted-by":"crossref","unstructured":"Zhu H et al (2022) Elevation of ADAM12 facilitates tumor progression by enhancing metastasis and immune infiltration in gastric cancer. Int J Oncol 60(5)","DOI":"10.3892\/ijo.2022.5341"}],"updated-by":[{"DOI":"10.1007\/s10528-024-10906-2","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2024,8,21]],"date-time":"2024-08-21T00:00:00Z","timestamp":1724198400000}}],"container-title":["Biochemical Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10528-024-10893-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10528-024-10893-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10528-024-10893-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T20:23:24Z","timestamp":1757103804000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10528-024-10893-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,27]]},"references-count":48,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["10893"],"URL":"https:\/\/doi.org\/10.1007\/s10528-024-10893-4","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s10528-024-10906-2","asserted-by":"object"}]},"ISSN":["0006-2928","1573-4927"],"issn-type":[{"value":"0006-2928","type":"print"},{"value":"1573-4927","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,27]]},"assertion":[{"value":"18 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2024","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s10528-024-10906-2","URL":"https:\/\/doi.org\/10.1007\/s10528-024-10906-2","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"None.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patients\u2019 Consent Form"}}]}}